• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
PoliticsCoronavirus

Biden tests negative for COVID after ‘rebound,’ will isolate until confirmed

By
Erin Prater
Erin Prater
Down Arrow Button Icon
By
Erin Prater
Erin Prater
Down Arrow Button Icon
August 6, 2022, 2:37 PM ET
U.S. President Joe Biden participates virtually in a meeting with his economic team in the South Court Auditorium of the White House campus July 22 in Washington, DC. On Thursday morning, the White House Press Office announced that U.S. President Joe Biden tested positive for COVID-19.
U.S. President Joe Biden participates virtually in a meeting with his economic team in the South Court Auditorium of the White House campus July 22 in Washington, DC. On Thursday morning, the White House Press Office announced that U.S. President Joe Biden tested positive for COVID-19.Drew Angerer—Getty Images

President Joe Biden tested negative for COVID-19 on Saturday after a “rebound” case of the virus, but will continue isolating until he receives another negative test, his doctor said.

“Strict isolation measures” will continue “in an abundance of caution,” Dr. Kevin O’Connor wrote in a daily update posted by the White House.

Biden—who initially tested positive July 21, after a week of traveling across the Middle East—tested negative for the virus on July 26 and 27, when he ended his isolation.

He additionally tested negative July 28 and July 29 before testing positive again July 30, according to a letter from O’Connor to White House Press Secretary Karine Jean-Pierre.

‘Rebound COVID,’ Paxlovid and otherwise

Biden was treated with the COVID-19 antiviral Paxlovid the day he was diagnosed, according to multiple news outlets. It’s a pill approved for treatment of COVID-19 in high-risk adults like the elderly, having received emergency-use authorization from the U.S. Food and Drug Administration.

But the drug is known for “rebound” cases, referred to by the U.S. Centers for Disease Control and Prevention as “a brief return of symptoms.”

Such rebounds, however, can happen with or without Paxlovid, Andy Pekosz, virologist at the Johns Hopkins Bloomberg School of Public Health, recently told Fortune.

“It’s not uncommon for people to have a positive test a few days after a negative test with COVID-19,” he said. “What I think people are more focused on these days is if this may be a Paxlovid rebound, meaning he’ll have a recurrence of the virus.”

While the U.S. Centers for Disease Control and Prevention says that COVID rebounds are rare, they could be more common than we know, as most individuals with COVID stop testing after they receive a negative result.

“The White House does a very good job of testing people on a daily basis,” Pekosz said. “They’re much more likely to catch some of these rare things with that level of frequency.”

The president’s rebound positive test was an antigen, or rapid, test, O’Connor wrote. Antigen tests are superior when it comes to gauging whether or not someone is shedding live virus and, therefore, infectious, Pekosz said, adding that a positive antigen test is “probably a good reason to go back into isolation.”

Fauci’s Paxlovid rebound

When diagnosed with COVID in June, chief presidential medical adviser Dr. Anthony Fauci was prescribed the antiviral due to his advanced age, which put him at greater risk for a severe outcome from COVID, despite being fully vaccinated and twice boosted.

Fauci later said he had experienced a Paxlovid rebound.

“After I finished the five days of Paxlovid, I reverted to negative on an antigen test for three days in a row,” Fauci, 81, said during an event at Foreign Policy’s Global Health Forum, Bloombergreported. “And then on the fourth day, just to be absolutely certain, I tested myself again.”

“I reverted back to positive.”

Fauci later told the New York Times that Paxlovid kept him out of the hospital and stopped his infection from becoming more severe initially, saying, “Paxlovid did what it was supposed to do.”

Fauci began a second course of Paxlovid when symptoms emerged “much worse than the first go-around,” he said. In May the CDC issued a health advisory about such rebounds, saying there was no evidence that additional treatment is needed for rebound cases.

In June, Pfizer, which manufactures Paxlovid, announced that it would stop adding new participants to a trial of the drug among COVID patients at low risk of hospitalization and death. The study failed to demonstrate that the drug reduced symptoms, or hospitalizations and deaths, in a statistically significant way, according to Bloomberg.

But Paxlovid may be undeservedly gaining a bad rap, Pekosz cautioned.

“I’ll still point to the fact that it’s working in terms of keeping people out of the hospital—that’s the most important thing right now,” he said, adding that it may need to be retooled to better address Omicron subvariants.

How long to quarantine?

The CDC currently advises COVID-positive individuals to quarantine for five days before returning to normal life (and masking in public for an additional five days). The recommended isolation time was 10 days until December, when the federal health agency halved it.

But “there is not data to support five days or anything shorter than 10 days,” Amy Barczak, a physician at the Massachusetts General Hospital Infectious Disease Division, recently told Nature.

Some scientists have questioned the rationale behind the policy since the CDC introduced it late last year. And now critics have more data to back up their claims: Viral shedding can occur beyond 10 days in even healthy, vaccinated adults, according to a preprint out of London published this month.

Some scientists advise that people stop quarantining only once they test negative using at-home tests, rather than relying on the CDC’s five-day rule alone.

Biden did so, however, testing negative at five and then six days after infection before ending his isolation. The White House had said that Biden would go “above and beyond” the CDC’s five-day guidance and wait until he tested negative before returning to public life.

He apparently wasn’t expecting a rebound.

Sign up for the Fortune Features email list so you don’t miss our biggest features, exclusive interviews, and investigations.
About the Author
By Erin Prater
See full bioRight Arrow Button Icon

Latest in Politics

EconomyFederal Reserve
The Fed just ‘Trump-proofed’ itself with a unanimous move to preempt a potential leadership shakeup
By Jason MaDecember 12, 2025
41 minutes ago
Trump
PoliticsWhite House
House Democrats release new Epstein photos including Trump, Clinton, Prince Andrew
By Stephen Groves and The Associated PressDecember 12, 2025
1 hour ago
Sherrone Moore
LawMichigan
Michigan mystery revealed: Fired football coach had broken into a lover’s apartment and threatened to kill himself when their affair ended
By Ed White and The Associated PressDecember 12, 2025
2 hours ago
Donald Trump
HealthHealth Insurance
‘Tragedy in the making’: Top healthcare exec on why insurance will spike to subsidize a tax cut to millionaires and billionaires
By Nick LichtenbergDecember 12, 2025
2 hours ago
Donald Trump, sitting in the Roosevelt Room, looks forward and frowns.
EconomyTariffs and trade
For the first time since Trump’s tariff rollout, import tax revenue has fallen, threatening his lofty plans to slash the $38 trillion national debt
By Sasha RogelbergDecember 12, 2025
3 hours ago
Donald Trump
AIElections
AI is powering Trump’s economy, but American voters are getting worried
By Mark Niquette, Nancy Cook and BloombergDecember 12, 2025
7 hours ago

Most Popular

placeholder alt text
Economy
Tariffs are taxes and they were used to finance the federal government until the 1913 income tax. A top economist breaks it down
By Kent JonesDecember 12, 2025
11 hours ago
placeholder alt text
Success
At 18, doctors gave him three hours to live. He played video games from his hospital bed—and now, he’s built a $10 million-a-year video game studio
By Preston ForeDecember 10, 2025
3 days ago
placeholder alt text
Success
Palantir cofounder calls elite college undergrads a ‘loser generation’ as data reveals rise in students seeking support for disabilities, like ADHD
By Preston ForeDecember 11, 2025
1 day ago
placeholder alt text
Investing
Baby boomers have now 'gobbled up' nearly one-third of America's wealth share, and they're leaving Gen Z and millennials behind
By Sasha RogelbergDecember 8, 2025
4 days ago
placeholder alt text
Arts & Entertainment
'We're not just going to want to be fed AI slop for 16 hours a day': Analyst sees Disney/OpenAI deal as a dividing line in entertainment history
By Nick LichtenbergDecember 11, 2025
24 hours ago
placeholder alt text
Uncategorized
Transforming customer support through intelligent AI operations
By Lauren ChomiukNovember 26, 2025
16 days ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.